Seeing Is Believing
SRPT is currently covered by 22 analysts with an average price target of $161.28. This is a potential upside of $43.99 (37.51%) from yesterday's end of day stock price of $117.29.
Sarepta Therapeutics's activity chart (see below) currently has 545 price targets and 503 ratings on display. The stock rating distribution of SRPT is 80.36% BUY and 19.64% HOLD.
Analysts average stock forecasts to be materialized ratio is 56.92% with an average time for these price targets to be met of 234.98 days.
Highest price target for SRPT is $224, Lowest price target is $103, average price target is $161.28.
Most recent stock forecast was given by COLIN BRISTOW from UBS on 01-Mar-2024. First documented stock forecast 20-Mar-2013.
Currently out of the existing stock ratings of SRPT, 90 are a BUY (80.36%), 22 are a HOLD (19.64%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
167
$40.61 (32.13%)
174
1 months 18 days ago
1/6 (16.67%)
$38.33 (29.79%)
39
Buy
172
$45.61 (36.09%)
113
1 months 21 days ago
1/3 (33.33%)
$44.1 (34.48%)
27
Buy
157
$30.61 (24.22%)
151
1 months 21 days ago
10/39 (25.64%)
$29.1 (22.75%)
397
Hold
128
$1.61 (1.27%)
128
1 months 21 days ago
3/8 (37.5%)
$0.1 (0.08%)
61
Buy
166
$39.61 (31.34%)
169
1 months 21 days ago
8/19 (42.11%)
$38.1 (29.79%)
248
What is SRPT (Sarepta Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on SRPT (Sarepta Therapeutics) with a proven track record?
Which analyst has the most public recommendations on SRPT (Sarepta Therapeutics)?
Which analyst is the currently most bullish on SRPT (Sarepta Therapeutics)?
Which analyst is the currently most reserved on SRPT (Sarepta Therapeutics)?